SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001564590-21-009495
Filing Date
2021-02-26
Accepted
2021-02-26 17:08:44
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 srne-s3.htm S-3 330712
2 EX-5.1 srne-ex51_6.htm EX-5.1 23552
3 EX-23.1 srne-ex231_82.htm EX-23.1 2600
4 EX-23.2 srne-ex232_100.htm EX-23.2 2397
5 GRAPHIC g5fnvextvamt000002.jpg GRAPHIC 17368
6 GRAPHIC gofaue1okqmb000001.jpg GRAPHIC 9950
7 GRAPHIC g5fnvextvamt000001.jpg GRAPHIC 11444
8 GRAPHIC g5fnvextvamt000003.jpg GRAPHIC 8832
9 GRAPHIC gofaue1okqmb000002.jpg GRAPHIC 9950
  Complete submission text file 0001564590-21-009495.txt   440340
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-253646 | Film No.: 21690882
SIC: 2836 Biological Products, (No Diagnostic Substances)